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Summary
Chronic prenatal stress contributes to poor birth outcomes for women and infants. Importantly, poor
birth outcomes are most common among minority and low income women. To investigate underlying
mechanisms, we tested the hypothesis that chronic stress related to minority or low income status is
associated with glucocorticoid resistance as indicated by disruption in the cytokine-glucocorticoid
feedback circuit. Home visits were conducted during which 3rd trimester pregnant women completed
stress and depression surveys and provided blood for pro- and anti-inflammatory cytokines. Saliva was
collected 5 times the preceding day for diurnal cortisol levels. For statistical analyses, women were
grouped 3 ways, by race, income, and the presence or absence of either of those risk factors; this last
group was labeled high or low general risk. Immune regulation was evaluated by evidence of a
functioning negative feedback relationship between cytokines and cortisol. Of 96 participants, 18 were
minority, 22 of low income, and 29 either minority or low income (high general risk). Pearson partial
correlation identified a significant negative relationship between cortisol area under the curve (AUC)
and pro- to anti-inflammatory cytokine ratios in the low general risk women (i.e., Caucasian, higher
income) including IFNγ/IL10 (r = −0.73, p < 0.0001), IL6/IL10 (r = −0.38, p = 0.01), IL1β/IL10
(r = −0.44, p = 0.004) and TNFα/IL10 (r = −0.41; p = 0.005); no such correlations existed in the high
general risk women (i.e., minority, low income) for (IFNγ/IL10: r = −0.25, p = 0.43;
IL6/IL10: r = 0.12, p = 0.70; IL1 β/IL10: r = 0.05, p = 0.87; TNFα/IL10: r = 0.10; p = 0.75), suggestive of
glucocorticoid resistance. Cortisol levels throughout the day also were higher in minority and high
general risk groups (p < 0.05). Without cytokine glucocorticoid feedback, a pregnant woman's ability to
regulate inflammation is limited, potentially contributing to adverse maternal and infant outcomes.
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Chronic prenatal stress contributes to adverse perinatal outcomes, including preterm birth (Institute of
Medicine, 2007), intrauterine growth retardation (Nordentoft et al., 1996), and spontaneous
miscarriage (Institute of Medicine, 2007). Infants born premature may experience mental and physical
disabilities that last a lifetime (Calkins and Devaskar, 2011). Even infants born at or near term whose
mothers were exposed to prenatal stress have increased risk of abnormal neurological development
(Davis et al., 2011, Talge et al., 2007), infectious disease (Tegethoff et al., 2011), congenital
malformation (Tegethoff et al., 2011), poor executive functioning (Buss et al., 2011), and mood or

behavioral disturbance (Wadhwa, 2005). Although progress has been made to clarify key mechanisms
underlying the associations between prenatal stress and adverse pregnancy outcomes (Karrow,
2006, Meaney et al., 2007, Sandman et al., 2011, Weaver, 2007), additional research is required to
determine how perturbations in stress-related biological responses conspire to influence poor birth
outcomes in high-risk populations (Kramer et al., 2011)
With mental or physical stress, a complex neuroendocrine-immune response is initiated (Sapolsky et
al., 2000) that includes activation of the hypothalamic-pituitary-adrenal (HPA) axis and stimulation of
the innate immune response, leading to the increased release of pro-inflammatory cytokines (Steptoe
et al., 2007, Yang and Glaser, 2002). This response carries benefits as well as risks for a pregnant
woman and her offspring. Acute inflammation offers protection from infection and supports healing.
However, even acute inflammation increases the risk of premature delivery (Romero et al., 2006) while
chronic inflammation carries additional complications, including gestational hypertension (Freeman et
al., 2004) and diabetes (Richardson and Carpenter, 2007). Fetal exposure to prenatal inflammation is
also under investigation for contributions to fetal growth restriction (Almasry et al., 2012) and
childhood diagnosis of autism (Angelidou et al., 2012). Finally, pro-inflammatory cytokines are
associated with sickness symptoms, that include fatigue, decreased sleep, poor cognitive function, and
depressed mood (Dantzer and Kelley, 2007), each having the potential to impact maternal health.
Mechanisms are in place, during pregnancy (Elenkov et al., 2001) and at other times, to regulate
inflammation including a key cytokine-glucocorticoid negative feedback circuit (Besedovsky and del
Rey, 2006, Elenkov et al., 2005). Pro-inflammatory cytokines are potent activators of the hypothalamicpituitary-adrenal (HPA) axis, and contribute to stress-induced elevation in cortisol secretion. Cortisol in
turn, is not only important in mobilizing resources to respond to the stressor, but also plays a
fundamental role in limiting the inflammatory response and the further production of cytokines
(Anisman and Merali, 2003, Besedovsky and del Rey, 2006, Yang and Glaser, 2002). This occurs through
synergistic, organized mechanisms (Pace and Miller, 2009), initiated by cortisol binding to
glucocorticoid receptors present on immune cells that are critical for regulation of the inflammatory
response, such as monocytes and lymphocytes. Considerable evidence suggests that activation of the
glucocorticoid receptor attenuates activity of inflammatory signaling pathways, including those that
promote production of pro-inflammatory cytokines, while activating pathways that promote
production of anti-inflammatory cytokines.
In the case of chronic stress, it has been suggested that prolonged activation of the stress response can
promote a state of glucococorticoid resistance that involves an inability of cortisol to inhibit proinflammatory signaling pathways, leading to a loss of the normal negative association between cortisol
concentration and various indicators of inflammatory immune activation (Pace et al., 2007, Stark et al.,
2001). For example, the negative correlation between plasma cortisol concentration and circulating
leukocyte subsets seen in non-stressed individuals was lost in subjects experiencing a major chronic
stressor during the preceding year, a finding identified as consistent with glucocorticoid resistance
(Cohen et al., 2012). Among the mechanisms hypothesized for glucocorticoid resistance include the
impact of stress-induced pro-inflammatory cytokine production on glucocorticoid receptor function
(Engler et al., 2008, Raison and Miller, 2003) and that sustained elevations in cortisol in response to
chronic stress lead to functional resistance to GR signal transduction (Miller et al., 2008). Ultimately,

pro-inflammatory cytokine production can become dysregulated regardless of cortisol levels.
Glucocorticoid resistance in response to chronic stress has been identified in caregivers of persons with
cancer (Miller et al., 2008), parents of children with cancer (Miller et al., 2002), adults with a history of
low early-life social class (Miller et al., 2009), and in women suffering post-traumatic stress syndrome
(Pace et al., 2012a).
Although most research on stress and inflammation has focused on non-pregnant
individuals, Coussons-Read et al. (2005), in a study of twenty-six pregnant women, reported a positive
correlation between self-reported stress and maternal serum levels of pro-inflammatory cytokines
interleukin-6 (IL-6) and tumor-necrosis factor-alpha (TNF-α), and a negative correlation between stress
and the anti-inflammatory cytokine interleukin-10 (IL-10). These findings suggested a mechanism by
which chronic prenatal stress could be linked to adverse pregnancy outcomes. Subsequent reports by
the same researchers furthered these findings (Coussons-Read et al., 2007), including most recently a
report identifying a linkage between elevated serum cytokines and preterm birth (Coussons-Read et
al., 2012). Others, however, have not confirmed a linkage between prenatal stress and either pro-or
anti-inflammatory cytokines during pregnancy or preterm birth (Blackmore et al., 2011, Christian et al.,
2010).
The relationship between chronic prenatal stress and adverse pregnancy outcome appears to be
moderated by race and social class, with minority and low income women disproportionately affected
(Institute of Medicine, 2007). After controlling for other variables (e.g., body mass index, smoking),
minority and low income women experience worse pregnancy outcomes, including a 64% increase in
preterm birth in African American women compared to white women (Institute of Medicine, 2007),
and their offspring fare worse in developmental, behavioral, and physical outcomes than infants born
to non-minority women (Reichman et al., 2008). Reproductive-age African American and low income
women also report increased levels of stress (Paul et al., 2008), a phenomenon these authors and
others (Dominguez, 2011, Rich-Edwards and Grizzard, 2005) ascribe to race and class discrimination.
Identifying the underlying mechanisms by which minority status and low income adversely affect
pregnant women and their offspring is essential. Based on the previous discussion and evidence of
increased inflammatory responses in other populations exposed to chronic stress, we tested the
hypothesis that minority status or low income during pregnancy (possible sources of chronic stress)
may be associated with dysregulation in the feedback relationship between pro-inflammatory
cytokines and cortisol. In addition, because of the effect of chronic stress on the HPA axis and the
inflammatory response, we also hypothesized that minority status or low income would be associated
with both increased plasma pro-inflammatory cytokine and salivary cortisol levels.

1. Methods
1.1. Subjects recruitment and inclusion/exclusion criteria
The subjects were 96 women in the second or early third trimester of pregnancy who responded to ads
placed in prenatal clinics and on community billboards. Subjects who met inclusion criteria during an
initial phone conversation were scheduled for a home visit during their 32–36th week of pregnancy.
Inclusion criteria were that each subject was between the ages of 18–40 years, anticipating a vaginal
birth of a singleton fetus, in good health without pregnancy restrictions, a non-smoker, not afflicted by

any disease that might affect the immune or endocrine systems and not taking any chronic
medications including anti-inflammatory agents. These criteria were established to reduce to the
extent possible conditions that might themselves be associated with inflammation or endocrine
disorder. Subjects also were required to live within a 20 miles of the laboratory, to minimize the time
biological samples were in transport, thereby preserving the validity of the biomarkers examined.

1.2. Procedure
At the start of the first home visit, the study protocol was reviewed, and participants provided
informed consent for their participation; as a result, all procedures were carried out with the adequate
understanding and written consent of the subjects. Participants then completed a demographic
questionnaire detailing age, marital status, height, pre-pregnancy weight, race/ethnicity, and whether
or not they currently were receiving government financial assistance. Self-reported height and weight
were used to estimate pre-pregnancy body mass index (BMI). Participants were also trained to collect
saliva samples using Salivette swabs (Sarstedt, Numbrecht, Germany). Instructions included being
directed to rinse their mouths out with water and then place the roll-shaped saliva swab in their
mouth, roll it around for 60 s then remove the swab and place it in the labeled tube, cap the tube, and
place it in their home refrigerator, inside the small, padded tote provided to them. Subjects were
additionally instructed not to eat or brush their teeth for at least half an hour before collecting saliva.
Subjects practiced the technique with a sample swab under the observation of the research nurse, and
then were provided the saliva collection kit. At the end of this training visit, a second home visit was
arranged for sample collection and completion of questionnaires; this visit typically occurred within 7days of the training visit and lasted approximately 30 min. All sample collection visits were conducted
by registered nurses between 3:30 and 4:30 PM to control for diurnal variability in both cortisol and
cytokines. Subjects were compensated for both home visits.
During the sample collection home visit, subjects provided a fresh saliva sample after which they
completed the Perceived Stress Scale (PSS), the Edinburgh Postnatal Depression Scale (EPDS), and a
questionnaire asking about their current health, including whether they were experiencing any
symptoms of infection. Lastly, blood was drawn from the antecubital vein into EDTA-containing tubes
for later measurement of plasma pro-inflammatory cytokines IL-6, IL-1β, TNF-α, and interferon-gamma
(IFN-γ), and anti-inflammatory cytokine IL-10. In addition, on the day preceding the home visit, each
woman collected salivary samples upon awakening, 30-min later, and at 11:00 AM, 4:00 PM, and
8:00 PM. To encourage compliance with and accuracy of diurnal salivary collections, each subject was
provided a study phone programmed to receive in-coming calls only, and was called the night before
the collections were to occur, and the next day, approximately 5-min prior to each of the scheduled
saliva collections. Subjects were compensated additionally each time they answered the phone. To
verify the times of sample collections, the saliva swabs were kept in Medical Electronic Monitoring
System [[MEMS®], Aprex Corp., Fremont, Calif.)] containers. Each time a sample was taken, the
participant would have to remove the MEMS® cap, thereby recording the time of the event. Subjects
whose sample collections were shown to have been taken at the correct times when the MEMS® cap
data were read later in the lab, also received additional compensation. Accurate sample collection was
defined by MEMS® cap readings within 60 min of the designated time, except for the 30-min postawakening sample. During the 8:00 PM phone call, subjects were reminded of the next day's visit. All
samples were kept on ice until reaching the laboratory where they were processed as described below.

1.3. Questionnaires
Questionnaires included the 14-item Perceived Stress Scale (PSS) which was used to provide
information on participants’ perception of stress (Cohen et al., 1983). The responses are based on a
Likert-scale from 0 to 4, or from “never” to “very often.” Each question asks the individual how she has
been feeling during the past month. The final score is a simple sum of each item response, with some
items reverse coded. In Cohen's original report, internal consistency reliability was high (Cronbach's
alpha coefficients ranged from 0.84–0.86) as was test-retest correlation (0.85). Evidence for concurrent
and predictive validity was significant at p < 0.05 (r = 0.49). Scores on the PSS have been shown to
correlate with measures of HPA axis function during pregnancy and the postpartum period (Ruiz et al.,
2003).
The 10-item EPDS was used for self-report of symptoms of depression (Cox et al., 1987). It is an easy to
administer and effective screening tool that has been validated for both antepartum and postpartum
use. Answers to questions such as “I have looked forward with enjoyment to things” are scored from 0
(“As much as I ever did”) to 4 (“Hardly at all”). After completion, a woman's score is summed to
provide information on the likelihood of clinical depression. Validation of the EPDS against a diagnostic
clinical interview identified a specificity of 78%, a sensitivity of 86%, and a positive predictive value of
73% for women scoring >10 (Cox et al., 1987).

1.4. Biomarker measurement
Upon reaching the laboratory, blood samples were centrifuged at 4 °C for 8 min at 2000 rpm. Plasma
aliquots were placed into 1.5 cc polypropylene microtubes and stored separately in the study lab, at
−70° C, until assayed using a Human Pro-inflammatory Ultra-Sensitive assay and quantitative multiplex
array technology (Meso Scale Discovery, Gaithersburg, Maryland). Intra-assay coefficient of variation
was <5% and inter-assay coefficient of variation was <10%. The level of each cytokine is reported as
well as the ratio of each pro-inflammatory cytokine to anti-inflammatory cytokine (e.g., IL-6/IL-10).
Measuring the pro- to anti-inflammatory ratio is a sensitive means by which to identify cytokine
equilibrium or disequilibrium (Petrovsky and Harrison, 1997).
Upon reaching the laboratory, salivary samples were centrifuged at 4 °C for 3 min at 3000 rpm and
aliquoted into 1.5 cc polypropylene microtubes for storage at the study lab at −70°C until assayed.
Salivary cortisol levels were determined using an expanded range high sensitivity EIA kit (No. 1-3002/13012, Salimetrics, State College, PA). The cortisol detection limit of the kit is .018 mg/dl and shows
minimal cross reactivity (4% or less) with other steroids. Intra-assay coefficient of variation was 4.3%
and inter-assay coefficient of variation was 5.2%. All samples were measured in duplicate. Area under
the curve (AUC) was calculated with respect to ground (Pruessner et al., 2003). The cortisol awakening
response was determined based on the difference in salivary cortisol concentration between that
measured at awakening to that measured 30-min post-awakening according to the following formula:
[30-min post-awakening – awakening]/awakening.

2. Statistical analysis
For comparative analyses, women were grouped three ways; first, as either Caucasian or of a
racial/ethnic minority (Race), and second, as being either of high or low income (Income). These
categories were determined by self-report of race/ethnicity and by self-report of participation in WIC

or other government assistance programs respectively. For the third group, women were separated
based on the presence or absence of either of the two risk factors: being minority or low income. This
category is identified in analyses as being of high or low general risk (General Risk). Demographic and
clinical characteristics were compared between the race, income and the general risk groups.
Continuous variables were compared using the independent sample Student t-test. Categorical
variables were compared using the Chi-square test or Fisher's exact test when appropriate.
Multiple linear regression was used to assess the difference in the plasma concentrations of cytokines
and pro- and anti-inflammatory cytokine ratios between each of the three subject groups (Race,
Income, General Risk). Demographic and clinical variables that were significantly related to these
groups were controlled for in the multiple linear regressions. Model-based mean and standard error
for the cytokine measurements were derived for each subgroup.
Linear mixed (hierarchical) models were performed on the salivary cortisol samples collected upon
awakening, 11:00 AM, 4:00 PM, and 8:00 PM to compare the overall temporal pattern in salivary
cortisol across the day between subject's groups. Linear mixed models were also performed on the
salivary cortisol samples collected upon awakening and 8:30 AM to compare the cortisol awakening
response between subject groups. An unstructured variance–covariance form in repeated
measurements within a woman was assumed, which provides the most flexible modeling of the
covariance structure. Subject-specific random effects were included in the mixed models to
accommodate between-subject variation in the cortisol level. The fixed effects in the mixed models
include subject group (Race, Income, General Risk), collection time of the sample and the interaction
between group and the collection time. The models also include demographic and clinical variables
that were found to be significant related to the group variable. The fitted mixed models provided
model-based estimates for mean cortisol level at each collection time point for different subject
groups. The differences in the temporal pattern of the cortisol between subject groups were evaluated
by testing the significance of the interaction term between group and time.
Pearson partial correlation coefficients were used to evaluate the association between daily average
salivary cortisol (area under the curve [AUC], calculated using awakening, 11:00 AM, 4:00 PM, and
8:00 PM samples) and pro- and anti-inflammatory cytokine ratios in each subject group while
controlling for relevant demographic and clinical variables. Probability values for the partial
correlations were computed to test the significance of the association.
In addition to evaluating the independent effects of race and income on the levels of cytokines and
salivary cortisol, we also performed additional statistical analyses to evaluate the interaction effects
between race and income on the outcome measures. Specifically, we examined the significance of the
interaction term between race and income in the multiple linear regression analyses of the plasma
concentrations of cytokines and pro- and anti-inflammatory cytokine ratios, controlling for
demographic and clinical variables that were significantly related to these groups. We also examined
the significance of the interaction term between race and income on salivary cortisol in the linear
mixed (hierarchical) models, controlling for relevant demographic and clinical variables. When there
were significant interaction effects between race and income, model-based hypothesis tests were
applied to evaluate the effect of income for each race group separately.

Because the cytokine and cortisol data were right-skewed, natural log transformations were performed
prior to the analysis and results were reported based on back transformation of the log values to the
original scale. Statistical analysis was performed using SAS (version 9.2; SAS Institute, Cary, NC) and
SPSS 20. All statistical tests were two-sided and a p value of <0.05 was considered statistically
significant.

3. Results
Demographic data for the 96 pregnant women in this study are included in Table 1. As shown, 18
participants self-reported minority racial or ethnic status, 11 of whom self-identified as African
American and 7 as Hispanic. Twenty two participants reported receiving government aid. Twenty-nine
were of minority status or reported receiving government aid and were categorized as the high general
risk group; 66 participants were Caucasian and did not receive government aid and were categorized as
the low general risk group. None of the participants reported or demonstrated symptoms of infection
or illness on the day of the home visit, although four reported a physical complaint: anemia, swelling,
allergies, or sciatica for which that woman had taken acetaminophen. With regards to birth outcomes,
7 women delivered by Cesarean section, (7.3%); one of whom was a minority and none of whom were
of low income; 2 women required a transfusion after delivery, both were Caucasian and neither of low
income; and one Caucasian, non-low income woman gave birth to an infant prematurely. There were
no statistically significant differences based on either race/ethnicity or income in these outcomes.
Table 1. Demographic and clinical characteristics of subjects.
Race
Income
Minority
Caucasian
Low
(N = 18)
(N = 78)
(N = 22)
Mean (SD)
Mean (SD)
Mean (SD)
**
Age
25.9(5.0)
29.6(4.9)
24.1(4.5)
BMI
25.1(4.8)
23.7(3.9)
26.1(5.4)
PSS
20.9(7.6)
19.6(6.4)
21.6(6.6)
EPDS 4.7(4.1)
4.4(3.3)
5.1(4.3)
Marital status N (%)
N (%) p = 0.10 N (%)
Other
1(5.6)
1(1.3)
2(9.1)
Single
3(16.7)
9(11.5)
7(31.9)
Married
11(61.1) 65(83.3)
10(45.5)
Partner
3(16.7)
3(3.9)
3(13.6)

General risk
High
High risk
(N = 73)
(N = 29)
Mean (SD)
Mean (SD)
***
30.3(4.5)
25.7(4.8)
*
23.4(3.4)
25.4(5.1)
19.3(6.6)
21.9(7.5)
4.3(3.1)
5.2(4.3)
N (%) p < 0.0001 N (%)
0(0)
2(6.9)
5(6.9)
7(24.1)
65(89.0)
16(55.2)
3(4.1)
4(13.8)

Low risk
(N = 66)
Mean (SD)
30.3(4.6)***
23.4(3.4)*
19.0(6.1)*
4.2(2.9)
N (%) p = 0.001
0(0)
5(7.6)
59(89.4)
2(3.0)

Notes: values presented are mean and standard deviation (SD) or percentages (%).
*p < 0.05.
**p < 0.001.
***p < .0001.

As shown in Table 1, the minority group was significantly younger than the Caucasian group (p = 0.005)
but was similar in BMI and marital status. Compared to the high income group, the low income group
was significantly younger (p < 0.0001), had higher BMI (p = 0.04) and had significantly lower

proportions of being married (p < 0.0001). Between the general risk groups, the high risk group was
significantly younger (p < 0.0001), had higher BMI (p = 0.05) and had significantly lower proportions of
being married (p = 0.001). Mean scores on the PSS were not significantly different between
racial/ethnic groups (p = 0.47) or income groups (p = 0.17). PSS was, however, elevated in the high
general risk group (p = 0.04).

3.1. Salivary cortisol
Of the more than 300 salivary samples collected, all but 2 were collected within the designated time
and both of those were inaccurate at the 8:00 PM sampling. All analyses were run with and without
those two samples; there were no differences in results so all samples were included in the reported
analyses.
Results from the linear mixed models of the salivary cortisol level are presented in Table 2 and Fig. 1.
Subjects with low income had a significantly different temporal pattern in cortisol across the day than
subjects with high income (p = 0.04; see Fig. 1B). There was no significant difference in the temporal
pattern of cortisol between Caucasian and minority women, however, minority women showed a
significantly higher level of cortisol than Caucasian women (p = 0.01; see Fig. 1A), especially in the time
points of 11 AM (p = 0.01), 4 PM (p = 0.04) and 8 PM (p = 0.06). There was likewise no significant
difference in the temporal pattern of cortisol between high general risk and low general risk groups.
However, high general risk women showed a significantly higher level of cortisol than low risk women
(p = 0.01; see Fig. 1C), again, especially in the time points of 11 AM (p = 0.001), 4 PM (p = 0.01) and
8 PM (p = 0.02). The change in cortisol from morning awakening to 30 min after was not significantly
different between the race groups, the income groups, or the general risk groups (Fig. 1).
Table 2. Results of linear mixed models of salivary cortisol samples (μg/dL) for race, income and
general risk groups.

Minority
Yes
No
p value for yes
vs. no
Income
High
Low
p value for
high vs.low
GenRisk
Low
High

Awake
Mean (SE)

11:00 AM
Mean
(SE)

4:00 PM
Mean
(SE)

8:00 PM
Mean
(SE)

Group Time
p value p value

Group × time
p value

0.43(0.06)
0.41(0.03)
p = 0.79

0.41(0.04) 0.23(0.03) 0.17(0.02) 0.01
0.31(0.01) 0.18(0.01) 0.13(0.01)
p = 0.01
p = 0.04
p = 0.06

<0.0001 0.64

0.42(0.04)
0.33(0.05)
p = 0.14

0.30(0.03) 0.17(0.02) 0.13(0.01) 0.52
0.38(0.04) 0.20(0.02) 0.15(0.02)
p = 0.05
p = 0.29
p = 0.36

<0.0001 0.04

0.39(0.04)
0.37(0.05)

0.27(0.02) 0.16(0.01) 0.12(0.01) 0.01
0.38(0.03) 0.21(0.02) 0.16(0.02)

<0.0001 0.10

p value for
p = 0.69
p = 0.001 p = 0.01
p = 0.02
high vs.low
Note: values presented are model-based mean and standard error (SE) of the salivary cortisol levels
(μg/dL). Potential confounding factors were controlled for in the linear mixed models.

Figure 1. Model-based mean salivary cortisol (μg/dL) at each time point for subject subgroups. Error bars
represent standard error of the mean.

After controlling for the appropriate demographic and physical variables, the cortisol concentration in
the salivary sample collected immediately upon arrival at the subject's homes was elevated in the
minority women (p = 0.01) compared to the Caucasian women, in women of low compared to high SES
(p = 0.02), and in women in the high general risk group compared to the low general risk group
(p = 0.004). These findings were concordant with the results based on cortisol samples collected by the
women on their own, on the day preceding the home visit.

3.2. Pro- and anti-inflammatory cytokines
Results based on multiple linear regression of the plasma cytokine measurements are presented
in Table 3. After controlling for age, marital status and BMI, there were no significant differences in
cytokine levels or cytokine ratios between the low versus high income group or between the low
general risk versus high general risk group. When considering minority race/ethnicity, the antiinflammatory cytokine IL-10 was marginally lower (p = 0.09) in minority compared to Caucasian
women.

Table 3. Cytokine profile of subjects Mean (SE) (pg/ml).
Race
Minority
(N = 12)
1.53(0.20)
2.27(0.23)
5.53(0.88)
1.86(0.25)
3.19(0.96)

Caucasian
(N = 52)
1.56(0.10)
2.35(0.11)
7.29(0.54)
2.20(0.14)
5.75(0.80)

p-value

Income
Low
(N = 15)
1.55(0.21)
2.37(0.25)
7.65(1.17)
2.02(0.30)
4.51(1.45)

High
(N = 48)
1.22(0.17)
2.37(0.26)
5.94(1.06)
1.98(0.30)
5.55(1.85)

p-value

General risk
High risk
(N = 20)
1.40(0.17)
2.33(0.22)
6.68(1.06)
1.97(0.27)
4.34(1.27)

Low risk
(N = 43)
1.36(0.18)
2.43(0.25)
6.93(1.19)
2.04(0.30)
5.93(1.87)

p-value

IL-1β
0.88
0.16
0.84
IL-6
0.78
0.99
0.68
TNFα
0.13
0.24
0.84
IFNγ
0.28
0.93
0.80
IL-10
0.09
0.61
0.34
Pro- to antiinflammatory
ratios
IL-1β/IL10
0.17(0.08)
0.10(0.02)
0.31
0.15(0.07)
0.06(0.03)
0.13
0.11(0.05)
0.08(0.04)
0.48
IL-6/IL-10
0.55(0.17)
0.34(0.04)
0.16
0.40(0.14)
0.38(0.12)
0.85
0.42(0.13)
0.36(0.12)
0.63
TNFα/IL10
1.73(0.49)
1.27(0.17)
0.32
1.70(0.51)
1.07(0.33)
0.22
1.54(0.43)
1.17(0.35)
0.37
IFNγ/IL-10
0.40(0.20)
0.22(0.05)
0.26
0.27(0.13)
0.18(0.09)
0.48
0.26(0.12)
0.18(0.09)
0.46
Notes: values presented are model-based mean and standard error (SE) for cytokine measurements, controlling for relevant demographic
and clinical variables. Natural log transformations were performed on the cytokine measurements prior to the analysis and results reported
in the table were back transformation of the log values to the usual arithmetic scale.

3.3. Correlation between pro-inflammatory cytokine and cortisol
After controlling for relevant demographic and physical characteristics, we identified significant
differences in the correlations between cortisol and cytokines between women within the general risk
group. Fig. 2 graphically displays the different patterns of association between cortisol AUC and pro- to
anti-inflammatory cytokine ratios in this group. As shown, there were significant negative correlations
in the low general risk women – as indicated by the negative slope (solid circles, blue lines) – between
daily average salivary cortisol AUC and pro- to anti-inflammatory cytokine ratios including IFNγ/IL-10
(Pearson's partial r = −0.73, p < 0.0001), IL6/IL-10 (r = −0.38, p = 0.01), IL1β/IL-10 (r = −0.44, p = 0.004),
and TNFα/IL-10 (Pearson's partial r = −0.41; p = 0.005). In contrast, there were no negative correlations
between any pro- to anti-inflammatory cytokine ratio and cortisol in the high general risk women
(IFNγ/IL10: Pearson's partial r = −0.25, p = 0.43; IL6/IL10: Pearson's partial r = 0.12, p = 0.70; IL1β/IL10:
Pearson's partial r = 0.05, p = 0.87; TNFα/IL10: Pearson's partial r = 0.10; p = 0.75), as indicated by the
relatively flat slopes (open circles, red lines) in Fig. 2.

Figure 2. Different patterns of association between cytokine and salivary cortisol in general risk groups (the
blue/red lines represent low/high general risk groups).

3.4. Interaction effects between race and income
After controlling for relevant demographic and physical characteristics, we found significant interaction
effects between race and income on IL1/IL10 ratio (p = 0.05). Specifically, the IL1/IL10 ratio was
significantly higher for those with low income vs. those with high income in the minority group
(p = 0.02). But this significant difference in IL1/IL10 ratio between low and high income women was not
found in the Caucasian group (p = 0.66). No significant interaction effects between race and income
were found on the salivary cortisol, controlling for relevant demographic and clinical variables

4. Discussion
In this report, we describe the effects of chronic social stress on the relationship between cortisol and
the pro-inflammatory cytokines in a uniquely vulnerable population, pregnant women. The most
significant finding is that chronic stress related to minority status or low income was associated with
elevated cortisol without a compensatory decrease in pro-inflammatory cytokine concentration; such a
diminished negative feedback relationship between cortisol and pro-inflammatory cytokines is
indicative of glucocorticoid resistance. Without negative feedback, an individual's ability to regulate

inflammation is limited. Although similar findings have been reported previously in patients with high
lifetime trauma exposure (O’Donovan et al., 2012), in caregivers of family members with cancer (Miller
et al., 2008, Miller et al., 2002) and in individuals with a lifetime exposure to low socioeconomic status
(Miller et al., 2009), to our knowledge, this is the first report to identify diminished negative feedback
as occurring in pregnant minority or low-income women.
Diminished regulation of the inflammatory response related to chronic stress in other populations has
been linked to glucocorticoid resistance (Cohen et al., 2012, Miller et al., 2009, Pace et al.,
2012b, Rohleder, 2012). Normally, binding of cortisol to the glucocorticoid receptor reduces WBC
production of pro-inflammatory cytokines by inhibiting NF-kappaB (NF-κB), a transcription factor that
regulates expression of pro-inflammatory genes (Pace et al., 2007, Pace et al., 2012a, Rohleder, 2012).
With chronic stress, this feedback circuit becomes disrupted (Besedovsky and del Rey, 2006). Since we
did not measure NF-κB activity we are unable to determine whether transcription factor activity was
increased in the minority and/or low income pregnant women compared to the white or more
economically advantaged women. The findings in this study highlight, however, the significant impact
of poverty and minority race/ethnicity on psychoneuroimmune functioning in pregnant women and
emphasize the need for future research in this important area.
Also not addressed in this study is whether dysregulated inflammation was present in the minority or
low income women before they became pregnant. Because all subjects were required to be nonsmokers with no chronic health conditions and not taking any medications or herbs on a regular basis,
we conclude that the indicators of dysregulated inflammation likely reflect a pre-existing vulnerability,
and are not due to disease or specific to pregnancy. This is in line with the concept of weathering
proposed by Geronimus to explain the unique and cumulative damage to the health of African
American women posed by racism and discrimination (Geronimus et al., 2006). In the data provided in
this report, a biological underpinning of weathering may be visible.
Likewise, our finding that minority status or low income was associated with elevated cortisol levels
during pregnancy is troubling at many levels. First, chronically elevated cortisol contributes to adverse
health conditions in non-pregnant individuals including obesity, hypertension, diabetes mellitus, and
cancer (Seeman et al., 2010), all disproportionately present in socially and economically disadvantaged
women (Arbour et al., 2012). In regard to pregnancy, a systematic review of the literature has
identified clear evidence of a relationship between premature birth and elevated maternal cortisol
levels (Giurgescu, 2009). In the current study, despite the high levels of salivary cortisol present
throughout the day in the high risk women, pro-inflammatory cytokine levels were not decreased,
which is explained by the finding of glucocorticoid resistance. This may be the “weathered state” that
is a vulnerability for disease. In addition, fetal exposure to elevated HPA activity may predispose
offspring to adulthood hypertension, obesity, and insulin resistance (Calkins and Devaskar, 2011).
Whether these adverse effects result from fetal exposure to neuroendocrine, cardiovascular, or
inflammatory stimuli or from epigenetic modification of the fetal brain remains under investigation
(Sandman et al., 2011).
Coussons-Read and colleagues (Coussons-Read et al., 2007, Coussons-Read et al., 2005) reported that
chronic stress is associated with elevated serum IL-6 and TNF-α in pregnant women, and subsequent
risk of preterm birth (Coussons-Read et al., 2012). Data from the present study did not find such

elevations in cytokines after controlling for appropriate demographic and physical variables. However,
we did find a trend toward lower levels of IL-10 in the minority women and an increase in the ratio of
Il-1/IL-10 in the minority group only. Ultimately, given the range of biologic, behavioral, and
socioeconomic factors that may affect cytokine levels, a larger sample size may be needed to provide
sufficient statistical power for detecting differences in cytokine levels between groups of pregnant
women.
The linkages between minority status, low income, chronic social stress, and the regulation of
inflammation, raise a host of implications when considering clinical strategies to promote health and
the prevention of illness. If an individual is affected physiologically simply due to the fact that he or she
is a member of a racial or ethnic minority or by being of low income, the benefits of typical prevention
and intervention strategies may be limited. This may explain why adding a behavioral intervention to
reduce or manage stress in African Americans with chronic disease significantly improves outcomes
compared to usual care (Schneider et al., 2005). Lastly, since chronic inflammation has been linked to
long term adverse health outcomes, if immune dysregulation exists outside pregnancy in minority and
low income women, their future health may be compromised as well.
As with all studies, there are important limitations to our findings. First, the sample was not a random
one, but a convenience sample. Inclusion was limited to only relatively healthy women between the
ages of 18–40 who did not smoke and were taking no chronic medications, making it difficult to
generalize to other groups of pregnant women. Likewise, only women motivated to contact the
research team, to follow the somewhat burdensome saliva collection protocol, and to allow a member
of the research team to come to their homes were included. Second, only one self-report measure of
stress was used (the PSS) that may not reflect perceived stress similarly across groups. Additionally,
social economic status of the subjects was assessed using the dichotomized measure of whether or not
subjects were participating in WIC, a government support program. A continuous scale of income may
have provided a more accurate measure of the social economics status of subjects. Third, although we
attempted to verify timing of salivary cortisol samples, and the MEMS caps’ records suggested
accuracy for nearly all of the women nearly all of the time, there is no absolute guarantee that subjects
did indeed collect their saliva samples at the correct time. There was, however, no indication, that
members of one race/ethnicity or income category were more or less likely to have accurate
collections. Fourth, the number of minority and low income participants was small, increasing the risk
of Type 2 error. Finally, the rates of surgical births were low and there were no differences in perinatal
outcomes between groups, both perhaps reflecting the bias of the study toward the inclusion of only
generally healthy pregnant women. This may also reflect the younger age of the minority and low
income women; the weathering hypothesis suggests that, at least for minority women, younger age is
associated with lower accumulated health burden and thus better pregnancy outcomes (Geronimus,
1996).
In summary, our findings suggest that pregnant minority or low-income women experience
dysregulation in the cytokine-glucocorticoid feedback circuit reflective of glucocorticoid resistance.
Such dysregulation carries the potential for significant health risks for less advantaged women and
their infants. Further mechanistic and interventional research into this critical area is required.
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